Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.72 USD
Change Today -0.0463 / -6.02%
Volume 121.1K
GTXI On Other Exchanges
As of 8:10 PM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

gtx inc (GTXI) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/30/14 - $1.70
52 Week Low
10/14/14 - $0.41
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for GTX INC (GTXI)

gtx inc (GTXI) Related Bloomberg News

View More Bloomberg News

gtx inc (GTXI) Related Businessweek News

No Related Businessweek News Found

gtx inc (GTXI) Details

GTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecules for the treatment of cancer and other serious medical conditions. Its lead product candidate, enobosarm (GTx-024), is in Phase 2 clinical trials for the treatment of women with advanced AR positive triple-negative breast cancer, and treatment of women with ER positive and AR positive advanced breast cancer. The company also develops Capesaris, an oral nonsteroidal estrogen receptor alpha agonist that is in Phase 2 clinical trial for secondary hormonal therapy in men with metastatic or nonmetastatic castration resistant prostate cancer. GTx, Inc. was founded in 1997 and is headquartered in Memphis, Tennessee.

25 Employees
Last Reported Date: 03/16/15
Founded in 1997

gtx inc (GTXI) Top Compensated Officers

Co-founder, Chief Executive Officer and Direc...
Total Annual Compensation: $466.7K
Chief Legal Officer, Vice President, General ...
Total Annual Compensation: $363.6K
Compensation as of Fiscal Year 2013.

gtx inc (GTXI) Key Developments

GTx Inc. Enters into License Agreement with the University of Tennessee Research Foundation

GTx Inc. has entered into a license agreement with the University of Tennessee Research Foundation. The agreement will result in GTx developing new therapies that can aid in the treatment of castration-resistant prostate cancer, which were created at the University of Tennessee.

NASDAQ Grants 180-Day Grace Period To GTx Inc. To Comply With Minimum Price Requirement

GTx Inc. has received a letter of non-compliance from NASDAQ due to its stock price falling below the $1 minimum bid requirement. The company has received approval from the NASDAQ Stock Market to transfer its listing from the NASDAQ Global Market to the NASDAQ Capital Market. The transfer was made official on March 19, 2015. On April 1, 2015, GTx was granted a 180-day grace period to comply with the $1 minimum price requirement. By September 28, 2015, the company's stock must trade above $1 for 10 consecutive business days. The company also intends to enact a reverse stock split, if necessary to eliminate the price deficiency.

GTX Inc. Proposes to Approve an Amendments to its Restated Certificate of Incorporation

GTX Inc. proposed to approve an amendment to company's restated certificate of incorporation to increase the number of authorized shares of company's common stock from 200,000,000 shares to 400,000,000 shares and to approve reverse stock split of GTx's common stock at a reverse stock split ratio ranging from one-for-five (1:5) and one-for-fifteen (1:15), inclusive; a corresponding reduction in the total number of authorized shares of GTx's common stock as illustrated in the tables under the caption of Reverse Stock Split of Common Stock and a Corresponding Reduction in Authorized Shares of Common Stock with the effectiveness of one of such amendments and the abandonment of the other amendments, or the abandonment of all amendments, to be determined by the Board of Directors prior to GTx's 2016 Annual Meeting of Stockholders, at the discretion of the Board of Directors at its AGM to be held on May 6, 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GTXI:US $0.72 USD -0.0463

GTXI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for GTXI.
View Industry Companies

Industry Analysis


Industry Average

Valuation GTXI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 6.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GTX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at